Media coverage
1
Media coverage
Title Heart disease: Experimental cancer drug may slow inflammation from atherosclerosis; High-profile coverage of the off-label use of Ozempic, a GLP-1 agonist, for weight loss, has meant that the type 2 diabetes drug has received a lot of bad press. As more s Media name/outlet Medical News Today Country/Territory United Kingdom Date 8/06/23 URL ct.moreover.com/?a=51006636666&p=1gw&v=1&x=GWUgIrF7pO52ziPkqp835g Persons Chiara Giannarelli